Elisa Erbetta

Padova, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Real-World Outcomes of DNA Damage Repair Altered Metastatic Castration-Resistant Prostate Cancer: Insights from FFPE-Based Genomic Profiling.

Real-World Outcomes of DNA Damage Repair Altered Metastatic Castration-Resistant Prostate Cancer: Insights from FFPE-Based Genomic Profiling.

Journal: Cancers

Published: June 10, 2026

Effectiveness and safety of avelumab maintenance in patients aged ≥75 years with advanced urothelial cancer: a sub-analysis of the meet-URO 25 (MALVA) study.

Effectiveness and safety of avelumab maintenance in patients aged ≥75 years with advanced urothelial cancer: a sub-analysis of the meet-URO 25 (MALVA) study.

Journal: Frontiers in immunology

Published: February 26, 2026

Choriocarcinoma: Diagnosis, treatment and management of a rare germ cell tumour. An update review.

Choriocarcinoma: Diagnosis, treatment and management of a rare germ cell tumour. An update review.

Journal: Tumori

Published: February 24, 2026

Choriocarcinoma: Diagnosis, treatment and management of a rare germ cell tumour. An update review.

Choriocarcinoma: Diagnosis, treatment and management of a rare germ cell tumour. An update review.

Journal: Tumori

Published: February 24, 2026

Concomitant medications and survival outcomes in patients receiving avelumab maintenance for advanced urothelial carcinoma: sub analysis of Meet-URO 25 study.

Concomitant medications and survival outcomes in patients receiving avelumab maintenance for advanced urothelial carcinoma: sub analysis of Meet-URO 25 study.

Journal: Clinical genitourinary cancer

Published: January 14, 2026

Site and number of metastases predict outcomes in avelumab maintenance for advanced UC: results from meet-URO 25.

Site and number of metastases predict outcomes in avelumab maintenance for advanced UC: results from meet-URO 25.

Journal: Cancer immunology, immunotherapy : CII

Published: October 14, 2025

Real-world effectiveness of Avelumab maintenance in advanced urothelial carcinoma: results from the Italian multicenter MALVA study (Meet-URO 25).

Real-world effectiveness of Avelumab maintenance in advanced urothelial carcinoma: results from the Italian multicenter MALVA study (Meet-URO 25).

Journal: The oncologist

Published: June 06, 2025

Skin metastasis of BRCA mutated prostate cancer: A case report and a brief review of literature.

Skin metastasis of BRCA mutated prostate cancer: A case report and a brief review of literature.

Journal: Medicine

Published: October 28, 2024

Systemic Inflammation Indexes and Risk of Immune-related Adverse Events in Patients With Metastatic Urothelial Carcinoma Treated With Immunotherapy.

Systemic Inflammation Indexes and Risk of Immune-related Adverse Events in Patients With Metastatic Urothelial Carcinoma Treated With Immunotherapy.

Journal: Anticancer research

Published: July 18, 2024

Advanced Non-Clear Cell Renal Cell Carcinoma Treatments and Survival: A Real-World Single-Centre Experience.

Advanced Non-Clear Cell Renal Cell Carcinoma Treatments and Survival: A Real-World Single-Centre Experience.

Journal: Cancers

Published: August 09, 2023

Prognostic role of systemic inflammation indexes in metastatic urothelial carcinoma treated with immunotherapy.

Prognostic role of systemic inflammation indexes in metastatic urothelial carcinoma treated with immunotherapy.

Journal: Future science OA

Published: March 17, 2023

Liver Metastases of Unknown Primary Renal Cell Carcinoma Treated With Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors: A Case Report and Literature Review.

Liver Metastases of Unknown Primary Renal Cell Carcinoma Treated With Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors: A Case Report and Literature Review.

Journal: Anticancer research

Published: January 30, 2023

Showing 1-12 of 15

Last Updated: 09/26/2026